InvestorsHub Logo
Followers 592
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: Titan V post# 38470

Friday, 02/24/2017 10:06:47 AM

Friday, February 24, 2017 10:06:47 AM

Post# of 48316
Okay. Yes that would send a positive message to the medical community of Merck's endorsement for the $ONCS registered clinical trial using $ONCS EP+IL12 on the Keytruda non-responders.

$ONCS is also looking for a Partnership that would pay for the entire anti-PD1 registered trial.